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In this review we present the current data on remodeling,
based on in vivo ultrasound imaging or postmortem histologic
analysis of native peripheral and coronary arteries from animal
models and studies in patients (coronary artery saphenous vein
bypass grafts, lesions of restenosis after balloon angioplasty and
other catheter-based interventions). Histologic and ultrasound
imaging studies of arteries with atherosclerosis and after vascular
injury reveal that arterial remodeling is common and that the
cross-sectional area of the vessel is not constant. Compensatory
enlargement, inadequate compensatory enlargement and shrink-
age at the site of atherosclerotic lesions occurs in coronary and
peripheral arteries. Current studies demonstrate that arterial
remodeling is a major determinant of vessel lumen size.
(J Am Coll Cardiol 1997;30:1149–64)
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The severity of lumen narrowing of atherosclerotic arteries has
long been believed to depend on the extent of accumulation of
plaque along the arterial wall. The changes in overall dimen-
sions of the arterial wall were not appreciated. Therefore, it
was thought that there was a direct relation between the
severity of lumen stenosis and plaque area size. Only recently
has it been appreciated that concomitant changes in the total
cross-sectional area of the arteries (vascular remodeling) occur
that are of the utmost importance in determining the final size
of the lumen and hence the degree of blood flow impairment
and severity of ischemia. Data gathered by histologic exami-
nation and ultrasound imaging of native arteries with athero-
sclerosis and after vascular injury, both in experimental models
and in patients, have shown that the cross-sectional area of the
vessel is not constant. Compensatory enlargement, inadequate
compensatory enlargement and shrinkage at the site of athero-
sclerotic lesions have all been described in coronary and
noncoronary arteries.
In this report we review the published data on remodeling
on the basis of in vivo ultrasound imaging or postmortem
histologic studies from 1) animal experiments in native iliofem-
oral and coronary arteries; 2) native human iliofemoral, ca-
rotid and coronary arteries; 3) coronary artery saphenous vein
bypass grafts; 4) lesions of restenosis after balloon angioplasty
in animal models (both coronary and noncoronary arteries);
and 5) lesions of restenosis in human coronary arteries after
catheter-based interventions. The methods used to assess
remodeling in the studies that we reviewed were either histo-
logic examination or ultrasound imaging of the arteries by
epicardial high resolution echocardiography (coronary arter-
ies), duplex ultrasound (carotid arteries) or intravascular ul-
trasound (IVUS) (for peripheral and coronary arteries), com-
bined in some of the studies with angiographic measurements
of lumen diameter. Both histologic and ultrasound imaging
studies (Fig. 1) enable measurement of the lumen cross-
sectional area of the artery (the area circumscribed by the
external elastic lamina [EEL area]), the internal elastic lamina
(IEL) area, the intimal area (IEL area minus lumen area) and
the medial area (EEL area minus IEL area). However, in
advanced and calcified lesions, acoustic shadowing prevents
detection of the IEL and EEL by ultrasound. The studies
described in this review have used either histomorphometric
methods or ultrasound imaging for measuring the various
components of the artery at the site of interest and comparing
them with either an adjacent reference site with the least
atheroma, a control group without atheroma or the same site
at different time points. Another method used in some studies
compares the difference in lumen size between the lesion site
and a reference point, or over time at the same site (by
angiography), with the difference in wall thickness (measured
by histologic analysis or ultrasound). If the decrease in lumen
size is less than the increase in vessel wall thickness, compen-
satory remodeling is considered to be present; but if the
reduction in lumen size is greater than the increase in vessel
wall area, then inadequate vascular remodeling or shrinkage is
considered to have occurred (Fig. 2).
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Atherosclerotic Disease: Native Lesions
Animal Models
Peripheral arteries (Table 1). Armstrong et al. (1) studied
the iliofemoral arteries of monkeys fed either an atherogenic
or a regular diet. After 1.5 years, the control animals had no
gross atherosclerotic lesions in the limb arteries, whereas those
fed the atherogenic diet developed atherosclerosis. After 6
years of the atherogenic diet, there was progression of the
lesions, with marked intimal thickening and deposition of
extracellular lipids. The media of the atherosclerotic arteries
showed focal thinning and atrophy; however, the total medial
mass was not changed. Despite marked intimal thickening, the
arterial lumen size tended to be larger in monkeys fed an
atherogenic diet than in the control monkeys, because of a
compensatory enlargement of the total circumference of the
artery (1) (Table 1). This study therefore suggested that
compensatory enlargement of the peripheral arteries occurs
during the early development of intimal thickening and pre-
vents narrowing of the arterial lumen.
Coronary arteries. Similarly, monkeys fed an atherogenic
diet developed diffuse coronary atherosclerosis, but coronary
artery lumen narrowing did not occur (2,3). Moreover, mon-
keys on an atherogenic diet that also exercised had greater
enlargement of the diameter of their coronary arteries and less
lumen narrowing than similar monkeys that did not exercise
(4). A paradoxic increase in lumen size, associated with an
increase in plaque size, was described in the left anterior
descending coronary artery (LAD) of monkeys fed an athero-
genic diet (Table 1) (3). This could be partially explained by
the loss of arterial wall mass due to thinning of the media in
these lesions (5), compensating for the increase in plaque area
or resulting in weakening of the arterial wall and remodeling,
which results in arterial dilation.
These experimental studies demonstrate that compensatory
enlargement is a prominent feature in early atherosclerosis in
the peripheral and coronary arteries of monkeys fed an
atherogenic diet.
Human Studies
Peripheral vascular studies (Table 2). Using IVUS,
Losordo et al. (6) assessed paired, adjacent normal and
atherosclerotic superficial femoral artery segments of patients
undergoing peripheral vascular interventions (Table 2). As
expected, the lumen area was smaller in the atherosclerotic
segments than in the reference sites with the least atheroscle-
rotic plaque area. However, at the same sites, the total arterial
cross-sectional area (EEL area) was larger in the atheroscle-
rotic sites than in the reference sites. Regression analysis
revealed a positive correlation between plaque area and EEL
area (R 5 0.70). These results confirmed that in human
femoral arteries, there is a compensatory expansion of the
Abbreviations and Acronyms
DCA 5 directional coronary atherectomy
EEL 5 external elastic lamina
IEL 5 internal elastic lamina
IVUS 5 intravascular ultrasound
LAD 5 left anterior descending coronary artery
PTCA 5 percutaneous transluminal coronary angioplasty
Figure 1. Top, IVUS image of a human coronary artery with mild
atherosclerosis. Bottom, The external elastic lamina (EEL), internal
elastic lamina (IEL), lumen, ultrasound catheter (C), media, plaque
and adventia are identified.
Figure 2. Diagrammatic representation of compensatory and inade-
quate remodeling of the arteries. If the decrease in lumen size is less
than the increase in vessel wall thickness, compensatory enlargement is
considered present, but if the reduction in lumen size is greater than
the increase in vessel wall area, then inadequate remodeling or
shrinkage is considered to have occurred.
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outer wall of the arteries at discrete sites of atherosclerotic
narrowing of the lumen. Moreover, arterial enlargement oc-
curred as a local response of the arterial wall to the narrowing
of the arterial lumen by the accumulation of atherosclerotic
plaque rather than a generalized response to the development
of atherosclerosis (6). However, Pasterkamp et al. (7) reported
that in more advanced femoral lesions, shrinkage of the
arterial wall may predominate (Table 2). Patients with claudi-
cation were studied by IVUS before routine balloon angio-
plasty of the superficial femoral artery. Ultrasound images
were selected every 0.5 cm from a total of 23 arterial segments
;10 cm in length. In addition, histologic analysis of postmor-
tem human femoral artery segments was performed (Table 2).
Both analyses showed that the IEL area of the segments with
,25% lumen cross-sectional stenosis tended to be larger than
the reference site. However, for lesions with .25% area
stenosis, the cross-sectional area of the vessel was smaller than
the IEL area at the reference site (i.e., shrinkage had occurred)
(7). The cross sections that showed arterial wall constriction
contained more plaque than the reference sites. Therefore, in
lesions with mild lumen stenosis, compensatory enlargement
dominates (6,7); however, in more advanced femoral artery
lesions, contraction of the vessel may contribute to the en-
croachment of the lumen by the expanding plaque. In another
study, using IVUS and histologic examination, Pasterkamp et
al. (8) found a large variation in the correlation of the
regression between plaque area and IEL area (r 5 20.40 to
0.89 for IVUS; r 5 20.13 to 0.91 for histologic analysis) and
slope (20.28 to 1.29 for IVUS; 20.18 to 1.32 for histologic
analysis). In the majority of the segments there was no
significant correlation between plaque area and IEL area.
Thus, there was considerable local variation in arterial remod-
eling (9). Pasterkamp et al. (9) hypothesized that compensa-
tory enlargement of the small arteries starts earlier because the
segments that tend to have compensatory enlargement are
usually smaller than segments without remodeling. It might be
that the same amount of plaque accumulation results in more
profound hemodynamic changes in small arteries than in larger
arteries (8). It has been suggested by Glagov et al. (10) as well
as by Fujii et al. (11) that the degree of compensatory
enlargement is greater in eccentric lesions with a partially
disease-free wall.
In patients with nonstenotic carotid plaques, three-
dimensional plaque reconstruction of high resolution duplex
Table 1. Simian Models (histologic studies)
Study (ref no.)
Artery
Studied Diet Duration Findings
Armstrong et al. (1) Iliofemoral Atherogenic vs. regular 1.5 or 6 yr Atherogenic-fed monkeys developed atherosclerosis; IA1; no
overall change in MA; focal atrophy; LCSA1 after 6 yr
Kramsch et al. (4) CAs Atherogenic (with or without
exercise) vs. regular
2 yr Among atherogenic-fed monkeys, CA diameter of exercising
monkeys was larger than that of nonexercising group;
exercising group had less atherosclerosis than atherogenic
diet nonexercising group
Clarkson et al. (3) LAD Atherogenic 6 yr IA1; LCSA1 after 6 yr
CA 5 coronary artery; IA 5 intimal area; LAD 5 left anterior descending coronary artery; LCSA 5 lumen cross-sectional area; MA 5 medial area; ref 5
reference; 1 5 increased.







Losordo et al. (6) 20 (62 segs) Femoral LCSA2 (16.7 vs. 21.1 mm2, p 5 0.0001), EEL1 (37.9 vs. 32.9 mm2, p 5 0.0001)
lesion vs. ref site; EEL1 as PA1; compensatory expansion of EEL at lesions of
atherosclerosis
Pasterkamp et al. (7) 19 (23 segs) Femoral IEL of segs with ,25% LCSA stenosis was larger than that at ref site; IEL of segs
with .25% LCSA stenosis was smaller than that at ref site
Histologic
Pasterkamp et al. (7) 32 Femoral IEL of segs with ,25% LCSA stenosis was larger than that at ref site; IEL of segs
with .25% LCSA stenosis was smaller than that at ref site; cross sections that
showed CSA shrinkage had larger PA than ref sites; lesions with mild PA showed
more compensatory enlargement; advanced lesion showed shrinkage
HRDS
Steinke et al. (12) 32 Carotid In pts with nonstenotic carotid plaques, plaque progression was associated with 1 in
OD of artery in 20 (77%) of 26 pts, whereas only 10 (28%) of 36 lesions without
change in PA had an 1 in OD (p , 0.001); no lesion had reduction in OD
CSA 5 cross sectional area; EEL 5 external elastic lamina area; HRDS 5 high resolution duplex scanning; IEL 5 internal elastic lamina area; IVUS 5
intravascular ultrasound; OD 5 outer diameter; PA 5 plaque area; Pts 5 patients; segs 5 segments; 2 5 decreased; 1 5 increase, increased; other abbreviations
as in Table 1.
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scans at baseline and at two follow-up examinations after 6- to
12-month intervals revealed plaque progression in 41%, re-
gression in 3% and no change in 56% of cases (Table 2) (12).
Most lesions with plaque progression were associated with
enlargement of the outer diameter of the artery, whereas
among lesions with unchanged plaque, less than one third had
an increase in arterial diameter. None of the duplex follow-up
analyses demonstrated a reduction in carotid artery diameter
(12). The degree of plaque progression was correlated (r 5 0.7,
p , 0.01) with the degree of arterial enlargement at the lesion
site. Hence, in the human carotid arteries, similar to femoral
arteries, progression of small atheromatous plaques is associ-
ated with arterial enlargement that delays the development of
lumen narrowing.
These studies clearly show that remodeling of human
femoral and carotid arteries is a dynamic process. Plaque
progression is usually associated with compensatory enlarge-
ment of the arterial wall, at least in the early stages of
atherosclerosis, whereas more advanced lesions may be asso-
ciated with incomplete enlargement or even constriction of the
arterial wall.
Coronary arteries. Histologic studies (Table 3). In a pio-
neering study of histologic sections of postmortem human left
main coronary arteries, Glagov et al. (10) detected a correla-
tion between the IEL area and the area of the lesion. Their
work demonstrates that coronary arteries enlarge as the plaque
area increases. When the lumen area was plotted against the
percent stenosis of the lumen area (Lesion area/IEL area 3
100), a biphasic relation was present. For lesions with ,40%
stenosis, there is no relation between lumen area and percent
stenosis, whereas when there is .40% stenosis, the lumen area
decreases markedly as the stenosis increases. In vessels with
#20% lumen stenosis, the IEL area correlates with lesion area,
indicating that for small lesions, vessel enlargement may even
overcompensate for the increase in plaque area. Therefore, as
in femoral and carotid arteries, compensatory enlargement of
the human left main coronary artery may delay the progression
of lumen stenosis induced by the enlarging atheromatous
plaque. However, when there is narrowing of .30% to 40% of
the “potential” lumen area (the IEL cross-sectional area that is
occupied by the plaque), a sharp decline in lumen area occurs
(10). Figure 3 is a schematic presentation of the possible
sequence of changes in atherosclerotic arteries.
Zarins et al. (13) investigated LAD samples taken at four
standard sites in 125 pressure–perfusion-fixed postmortem
human hearts. The IEL area correlated with the plaque area at
each LAD level (p , 0.0001). Stepwise regression analysis
revealed that plaque area was the major determinant of IEL
area at each LAD level. In the proximal LAD, the most
severely diseased arteries (highest quartile) had a larger plaque
area and a smaller lumen area than arteries in the lowest
quartile. However, as shown in Figure 4, the arteries in the
highest quartile had also 62% greater IEL area than the
arteries with the least plaque. Despite a 6.7-fold (670%) larger
plaque area, the lumen area decreased by only 25% due to
compensatory enlargement of the IEL area. In the midportion
of the LAD, the plaque area was 10 times larger in the highest
quartile; however, the lumen area was not different because of
an 80% increase in IEL size. As shown in Figure 4, in the distal
LAD segments, despite a 14-fold increase in plaque area, the
lumen area almost doubled because of a more than 2-fold
increase in IEL size. It was calculated that if no compensatory
enlargement of the arteries had occurred, the most severely
diseased proximal segments would have developed a 92%
lumen stenosis rather than the observed 25% stenosis, and
distally, a 65% lumen stenosis rather than the observed 85%
increase in lumen size, would have occurred. The distal LAD
segments demonstrated a greater propensity to enlarge in
response to expanding plaque than the proximal segments.
These findings are in accordance with those in human femoral
arteries (8), showing that arteries with smaller diameters tend
to have more compensatory enlargement than larger arteries.
Intrinsic local differences in wall composition, geometric con-
figuration and wall tension and differences in the rate of plaque
deposition may account for the varying tendency of different
arterial segments to develop stenosis or dilation. For example,
smaller arteries may have more smooth muscle and fewer
elastic and collagen fibers than larger ones.
In a postmortem coronary angiographic and histologic
study of human hearts with and without coronary artery
disease, Stiel et al. (14) found a significant correlation between
the IEL area and the plaque area. Because of this compensa-
tory enlargement of the vessels at the lesion site, the degree of
stenosis, assessed by in vitro angiography, is underestimated
compared with that assessed by histologic analysis.
Another postmortem histologic study (3) of coronary arter-
ies from patients (28 with and 72 without coronary artery
disease) also demonstrated compensatory dilation of the LAD
coronary artery in segments with atheromata. However, there
was a great deal of variability in lumen size. Paradoxically,
instead of a decrease in lumen size, the arteries have a small
increase in mean lumen size with increasing intimal area. The
plaque size could explain only 7.5% of the variability in lumen
area. Hence, lumen size and therefore severity of blood flow
impairment are determined mainly by factors other than the
size of the atheromatous plaque.
These histologic postmortem studies of coronary arteries
demonstrate that compensatory enlargement occurs in the
initial stages of atherosclerosis. Vascular remodeling may be
more pronounced in the distal parts of the coronary arteries
and may be an important mechanism in preventing encroach-
ment of the lumen by the expanding atheromatous plaque.
High frequency epicardial echocardiography (Table 3). Be-
fore the development of IVUS, McPherson et al. (15,16)
demonstrated that atherosclerotic plaques may be much larger,
and coronary artery disease more diffuse, than suspected by
angiographic evaluation. High frequency epicardial echocardi-
ography in patients with and without coronary artery disease
performed at the time of cardiac surgery showed that the
severity of lumen narrowing is not dependent on plaque size.
Atheromatous plaque can expand outward and not into the
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lumen, hence, not causing lumen compromise. In patients
without coronary artery disease, the total arterial cross-
sectional area and the lumen area taper from the proximal site
to the midportion of the artery. However, in patients with
coronary artery disease, instead of the normal tapering, the
total arterial area is larger, whereas the lumen area is smaller
at distal sites with stenotic lesions than the proximal portion of
the artery. These data provide additional evidence that com-
pensatory enlargement occurs at sites of coronary artery
narrowing.







Glagov et al. (10) 136 LMCA Correlation between IEL and PA (r 5 0.44, p , 0.001), suggesting that CAs enlarge as PA1.
Compensatory enlargement of LMCA may delay progression of LCSA stenosis induced by
PA expansion; however, when .30–40% of IEL is occupied by PA, a sharp decline in
LCSA occurs. In 42 vessels with $20% lumen stenosis, IEL correlates with LCSA (r 5 0.76,
p , 0.001). In these lesions, the LCSA1 2.3 mm2 for every 1-mm2 PA1
Zarins et al. (13) 125 (481 segs) LAD CSA1 in response to PA1, which can prevent lumen narrowing. In proximal LAD, the most
severely diseased CSAs (highest quartile) had a larger PA than CAs in lowest quartile (8.5
vs. 1.1 mm2) and a smaller LCSA (6.4 vs. 8.5 mm2, p 5 0.02). CAs in highest quartile also
had 62% greater IEL than CAs with least plaque (14.9 vs. 9.2 mm2, p 5 0.0001). In
midportion of LAD, PA was 10 times larger in highest quartile (5.4 vs. 0.5 mm2); however,
LCSA was not different due to 80% IEL1 (11.4 vs. 6.6 mm2, p 5 0.0001). In distal LAD
segs, despite a 14-fold PA1 (1.4 vs. 0.1 mm2 in highest vs. lowest quartile), LCSA1 (3.7 vs.
2.0 mm2, respectively, p 5 0.0004) because of IEL1 (5.1 vs. 2.1 mm2, respectively, p 5
0.0001). Compensatory enlargement was more profound in distal than proximal LAD
Stiel et al. (14) 40 CAs Significant correlation (r 5 0.85, p # 0.0001) between IEL and PA, suggesting that CAs
enlarge as PA expands
Clarkson et al. (3) 100 LAD Small LCSA1 with IA1. IA could explain only 7.5% of variability in LCSA. LCSA, and
therefore severity of blood flow impairment, is determined mainly by other factors and not
by PA
HREUS
McPherson et al. (15) 32 CAs Severity of LCSA narrowing is dependent not only on PA. There are cases in which the PA
expands without LA2.
McPherson et al. (16) 33 LAD/RCA CSA was larger, whereas LCSA was smaller, at stenotic lesions than at proximal CA.
IVUS
Hermiller et al. (17) 44 (80 segs) CAs IEL correlated with PA. For lesions with ,30% stenosis, IEL correlated well with PA (r 5
0.79, p 5 0.0001). For each 1-mm2 PA1, IEL1 2.7 mm2; however, %LCSA stenosis did not
correlate with absolute LCSA due to progressive IEL1; however, for .30% stenosis,
LCSA2 as PA1. Compensatory enlargement occurred in early (,30% stenosis) lesions.
Gerber et al. (18) 60 LMCA CSA of CA was larger in pts with than without plaque in LMCA (p , 0.001). CSA correlated
with PA. LCSA was comparable between CAs with ,40% LCSA stenosis and CAs without
plaque (24.0 vs. 24.2 mm2, respectively). However, LCSA2 sharply (to 14.9 mm2, p ,
0.001) in CAs with $40% LCSA stenosis
Nishioka et al. (19) 30 (35 segs) CAs CSA2 could explain 39% and 7% of LCSA2 in lesions with inadequate (n 5 9) and
intermediate remodeling (n 5 7), respectively. PA1 could explain 6% and 93%,
respectively. In lesions with adequate remodeling (n 5 19), 82%1 in CSA partially
compensated for 182%1 in PA
Mintz et al. (20) 550 (603 lesions) Inadequate remodeling (lesion EEL/ref site EEL # 0.78) found in 15% of lesions. Only
predictor of inadequate remodeling was arc of superficial lesion calcium
Nakamura et al. (21) 12 (60 segs) CAs In angiographically normal segs, LCSA1 (r 5 0.68, p 5 0.0001), CSA1 (r 5 0.87, p 5
0.0001), and IEL1 (r 5 0.87, p 5 0.0001) as PA1. Compensatory enlargement at lesion
site delayed development of angiographically detectable lumen narrowing
Fujjii et al. (11) 36 CAs Vascular remodeling kept LCSA open until area stenosis was .50%. Vascular remodeling
greater in eccentric than concentric lesions
Blank and Yeung (22) 55 (58 segs) CAs Concentric lesions showed more remodeling than eccentric lesions. Concentric lesions
exhibited highest remodeling when %PA was ,55% and showed lower indexes when %PA
.55%. Eccentric lesions showed compensatory remodeling only for %PA .55%




CAs For every mm2 increase in lesion site PA, pts with IDDM had significantly smaller CA CSA1
and, hence, more lumen compromise than either nondiabetic pts (p 5 0.0001) or pts with
NIDDM (p 5 0.0019)
HREUS 5 high resolution epicardial ultrasound; IDDM 5 insulin-dependent diabetes mellitus; LMCA 5 left main coronary artery; NIDDM 5 non–insulin-
dependent diabetes mellitus; RCA 5 right coronary artery; 2 5 decrease, decreased;1 5 increase, increases, increased; other abbreviations as in Tables 1 and 2.
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IVUS (Table 3). Hermiller et al. (17) studied human coro-
nary artery segments by IVUS and found, as in previous
studies, that the IEL area increases as the plaque area (IEL
area minus lumen area) increases. In vessels with ,30% lumen
area stenosis (plaque area divided by IEL area times 100), the
IEL area correlated well with plaque area. In lesions with
,30% stenosis, there was no correlation between percent area
stenosis and lumen area. However, in more advanced lesions,
lumen area significantly decreased. This finding suggests that
arterial “compensatory” enlargement mechanisms are very
effective for early atherosclerotic lesions; but as lesions become
more progressive, these mechanisms can no longer compen-
sate, and lumen narrowing occurs. IVUS studies by Gerber et
al. (18) found plaque in 45% of left main coronary arteries (27
of 60). In left main coronary arteries with plaque, the vessel
area was significantly larger than in those without atheroscle-
rotic plaque, and the degree of enlargement correlated with
plaque area (r 5 0.46). In accordance with the findings of
Glagov et al. (10), in patients with left main coronary arteries
with ,40% stenosis, the lumen area was not significantly
different from that in patients without left main coronary
artery plaque. However, the lumen area decreased sharply in
arteries with $40% stenosis (18). Thus, compensatory remod-
eling preserves lumen size in early lesions (,40% stenosis);
but when the plaque expands to occupy .40% of the cross-
sectional area of the vessel, this protective mechanism fails to
compensate for further increases in plaque mass, and the
lumen area decreases (10,17,18).
Nishioka et al. (19) used IVUS to evaluate to what extent
native coronary artery stenosis is accompanied by vessel wall
thickening or inadequate compensatory remodeling (relative
vessel constriction). Compensatory enlargement was consid-
ered present when the vessel area at the lesion site was larger
than that at the proximal reference site. Inadequate compen-
satory enlargement was considered present when the vessel
area at the lesion site was smaller than that at the distal
reference site, and intermediate remodeling was considered
present when the vessel cross-sectional area at the lesion site
was intermediate between the proximal and distal reference
sites. Figure 5 shows an artery with compensatory enlargement
of the vessel at a site of lumen narrowing (upper panel) and an
artery with inadequate enlargement of the vessel cross-
sectional area. In this example, the vessel cross-sectional area
at the lesion site was smaller than both the proximal and distal
reference sites. As shown in Figure 6, compensatory enlarge-
ment was observed in 54% (n 5 19), intermediate remodeling
in 20% (n 5 7) and inadequate remodeling in 26% (n 5 9) of
35 lesions. In lesions with inadequate remodeling, 39% and
61% of the decrease in arterial lumen area could be attributed
to the reduction in total cross-sectional area of the vessel and
Figure 3. Diagrammatic representation of
the possible sequence of changes in arteries
with atherosclerosis. Initially, the artery en-
larges (left to right in the diagram) as the
plaque progresses. Hence, lumen size does
not decrease. Early stages of lesion devel-
opment may even be associated with over-
compensation (increase in lumen size).
However, at .40% lumen stenosis, the ar-
tery no longer enlarges at a rate sufficient to
counterbalance the expansion of the athero-
sclerotic plaque, and lumen narrowing is no
longer prevented. Reproduced with permis-
sion from Glagov et al. (10).
Figure 4. Postmortem sections from LAD in human hearts. An
example of an artery from the quartile with the least intimal plaque
(left panels) and an example of an artery from the quartile with the
most intimal plaque (right panels). At the proximal part of the artery
(L1), the most diseased artery is enlarged, and the lumen size is
moderately decreased. At the midportion of the artery (L2 and L3),
arterial enlargement is comparable to the increase in intimal plaque
area, and therefore, lumen area does not change. At the more distal
part of the artery (L4), enlargement of the artery exceeds the rate of
plaque expansion, and lumen area paradoxically increases. Repro-
duced with permission from Zarins et al. (13).
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the increase in wall thickness (plaque expansion), respectively.
In the intermediate remodeling group, inadequate enlarge-
ment of the total cross-sectional area contributed 7%, and an
increase in wall thickness 93%, to the reduction of lumen area.
In contrast, in the compensatory enlargement group, there was
a marked increase in wall area (182%) that was partially (82%)
compensated by the increase in vessel cross-sectional area (19).
The report by Mintz et al. (20) corroborates the findings of
Nishioka et al. (19). Studying 603 lesions in 550 patients, Mintz
et al. found inadequate remodeling (Lesion EEL area/
Reference site EEL area ,0.78) in 15% of lesions. There was
only poor correlation between angiographic or IVUS indexes
of lesion severity and remodeling (20). The only predictor of
inadequate remodeling was the arc of superficial lesion cal-
cium (20). In angiographically normal coronary segments,
Nakamura et al. (21) found that the mean percent area
stenosis of these segments by IVUS was 36 6 5%. Both total
arterial cross-sectional area and IEL area increased as the
plaque expanded. The lumen area also increased as the plaque
area expanded. The medial area (EEL area minus IEL area)
did not correlate with the plaque area. Thus, this study also
confirms that compensatory enlargement at the sites of mild
arterial atherosclerosis appears to delay the development of
angiographically detectable lumen narrowing. In the early
stages of atherosclerosis, arterial enlargement may result in a
paradoxic increase in lumen size despite expansion of the
plaque area. Because there was no reduction in medial area,
this does not seem to be the mechanism of compensatory
enlargement.
It has been suggested (10,11) that the degree of compen-
satory enlargement would be greater in eccentric lesions with a
partly disease-free wall that can respond to vasodilatory stim-
ulation. Fujii et al. (11) found that the degree of vascular
remodeling was greater in eccentric than in concentric lesions.
In contrast, Blank and Yeung (22) report that remodeling is
more pronounced in concentric lesions. In their study, concen-
tric lesions showed remodeling relatively early, when the
plaque area occupied ,55% of the vessel area, but the degree
of remodeling was less for more advanced lesions (plaque area
.55% of the vessel area). Conversely, eccentric lesions showed
Figure 5. IVUS images of two coronary
arteries. Compensatory enlargement was
observed in one artery (top panels), but it
was inadequate in the second (bottom pan-
els). White dotted lines show the lumen–
intimal borders; white dotted lines with
white arrowheads indicate the external elas-
tic lamina (EEL). Top panels, Vessel cross-
sectional area (EEL area) at the lesion site
is larger than that at the proximal and distal
reference sites (28.5 vs. 15.9 and 13.1 mm2,
respectively). Bottom panels, vessel cross-
sectional area (EEL area) at the lesion site
is smaller than that at the proximal and
distal reference sites (18.2 vs. 27.7 and
24.2 mm2, respectively). Reproduced with
permission from Nishioka et al. (19).
Figure 6. Serial changes in vessel cross-
sectional area and lumen area from the
proximal to distal reference site in three
groups of patients with compensatory
enlargement, intermediate remodeling
and inadequate compensatory enlarge-
ment. The lumen area at the lesion site
was significantly (p , 0.01) smaller than
that at the proximal (P-Ref) and distal
reference sites (D-Ref) and almost iden-
tical among the three groups. The vessel
cross-sectional area (EEL area) at the
lesion site was significantly (p , 0.01)
larger in the compensatory enlargement
group and was significantly smaller in the
inadequate compensatory enlargement
group than that at the proximal and distal
reference sites. Error bars show standard
deviation for each measurement. Repro-
duced with permission from Nishioka et
al. (19).
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compensatory remodeling only in advanced lesions (plaque
area .55% of the vessel area) (22). This finding could be
possibly explained by concentric lesions having a vasodilatory
response that is impaired earlier (due to more diffuse disease)
than in eccentric lesions, hence the stimulus for remodeling
might start earlier.
In patients with insulin-dependent diabetes mellitus, the
adaptive remodeling in primary coronary lesions is blunted
(23). Kornowski et al. (23) compared patients with insulin-
dependent diabetes mellitus with patients with non–insulin-
dependent diabetes mellitus and patients without diabetes and
reported that for every mm2 increase in lesion site plaque area,
patients with insulin-dependent diabetes had a significantly
smaller increase in cross-sectional area of the artery and, as a
consequence, more lumen compromise than either nondiabetic
patients or patients with non–insulin-dependent diabetes mel-
litus. It has also been reported (24) that in smokers, in contrast
to nonsmokers, focal constriction at sites of stenosis is more
common than compensatory enlargement.
Remodeling in Coronary Artery Saphenous
Vein Bypass Grafts
Nishioka et al. (25) investigated whether compensatory
enlargement occurs in human coronary saphenous vein bypass
grafts. Forty-three saphenous vein grafts from patients who
had not undergone previous catheter intervention were as-
sessed by IVUS. In addition, seven fresh saphenous veins,
harvested from patients undergoing coronary artery bypass
surgery were investigated by IVUS. Lumen area was smaller at
the lesion site than at the reference site (5.5 vs. 15.8 mm2) or
in the fresh saphenous veins (16.5 mm2). Whereas vessel wall
area was larger at the lesion site (19.0 mm2) than at the
reference site (8.4 mm2) and fresh saphenous veins (7.4 mm2),
there was no difference in vessel cross-sectional area (24.5, 24.0
and 23.9 mm2 at the lesion site, reference site and fresh
saphenous veins, respectively) (Fig. 7). No focal enlargement
or constriction of the vessel was found at the lesion site. Thus,
the absence of focal compensatory enlargement appears to be
a potentially important contributing factor in the progression
of lumen stenosis in coronary saphenous vein bypass grafts. In
contrast, Mendelsohn et al. (26) and Ge et al. (27) found that
the cross-sectional area of vein grafts does increase at the
lesion site. Mendelsohn et al. (26) assessed 24 lesions in 21
saphenous vein grafts. The mean vessel area at the lesion site
was 25.4 6 8.2 versus 20.2 6 8.5 mm2 at the reference site (p ,
0.001). Vessel area was associated with plaque area (r 5 0.83).
Ge et al. (27) studied 43 saphenous vein bypass grafts and also
found that the cross-sectional area of the vessel at the lesion
site was 19.0 mm2 compared with 12.8 and 12.9 mm2 at the
proximal and distal reference sites. The difference between the
studies may be the presence of venous valves in the bypass
grafts in the latter studies. In the patients included in the study
by Nishioka et al. (25) and Siegel et al. (28), venous valves were
eliminated by the surgeons from the segments chosen for
saphenous vein bypass conduits. Venous graft atherosclerosis
is enhanced at the site of venous valves and, as shown in Figure
8, the cross-sectional area at these sites is larger than the
reference site. Hence, the increase in vessel area at the lesion
sites in the studies by Mendelsohn et al. (26) and Ge et al. (27)
may not be due to remodeling but rather to the presence of
atherosclerotic lesions at venous valves.
Restenosis After Percutaneous
Catheter Interventions
Restenosis is the most frequent complication of percutane-
ous revascularization and remains its most serious limitation
(29,30). Initially, neointimal hyperplasia was thought to be the
predominant mechanism of restenosis after balloon angio-
plasty on the basis of animal experimental models (31,32),
human autopsy studies (33,34) and histologic specimens ob-
tained by directional coronary atherectomy (DCA) (35,36).
However, numerous experimental and clinical interventions
have failed to reduce the incidence of restenosis (37,38). Most
of these studies were based on the assumption that smooth
muscle cell proliferation and migration and matrix synthesis
constitute the principal pathogenetic basis for restenosis (39–
42). These data suggest that in addition to intimal hyperplasia,
there are other mechanisms responsible for restenosis in
humans (38,43).
Figure 7. Comparison of lumen area, plaque area and vessel cross-
sectional area (EEL area) in saphenous vein bypass grafts at the
reference, intermediate and lesion sites. In saphenous vein bypass
grafts, lumen area gradually decreased and plaque area increased from
the reference site to the intermediate and lesion sites. However, the
vessel cross-sectional area remained similar. Hence, no compensatory
enlargement was found in venous bypass grafts. *p , 0.01. **p ,
0.001. Reproduced with permission from Nishioka et al. (25).
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Animal Models
Rabbit models. Table 4 cites six recent studies of restenosis
in rabbit arteries (five in the iliofemoral and one in the carotid
artery). Most of these studies show that intimal hyperplasia
only partially explains the late loss in lumen area (44,45).
Kakuta et al. (46) reported compensatory enlargement of the
IEL area at the site of balloon angioplasty 4 weeks after the
procedure versus immediately after PTCA. However, their
conclusions might be limited because the investigators ligated
the distal femoral arteries after balloon angioplasty of the iliac
arteries. No control group in which ligation of the femoral
arteries was performed without angioplasty is presented. It
might be that the enlargement of the vessel was due to the
increased resistance after ligation of the femoral arteries.
Nevertheless, the restenotic lesions had a significantly smaller
total cross-sectional (IEL) area than the nonrestenotic lesions.
In the restenotic lesions, the slope of the correlation between
IEL area and intimal area was ,1, indicating inadequate
compensatory enlargement, whereas in the nonrestenotic le-
sions, the slope was .1, indicating adequate remodeling (46).
In contrast, Post et al. (44), Lafont et al. (45) and Makkar et al.
(47) found constriction of the vessel wall at sites of restenosis.
Moreover, quantitative analyses showed it to be the major
mechanism for lumen narrowing rather than intimal hyperpla-
sia and accounted for 77% to 86% of the reduction in lumen
area (44). Nevertheless, Gertz et al. (48) reported that 28 days
after balloon angioplasty in atherogenic diet-fed rabbits, the
EEL area at restenotic sites was comparable to that of adjacent
segments or even larger. Although they concluded that an
increase in plaque area accounts for the late lumen narrowing
after balloon angioplasty, recent data suggest that remodeling
is the predominant mechanism of restenosis.
Porcine models. Post et al. (44) demonstrated that only
11 6 11% of the late lumen diameter loss in the iliofemoral
arteries could be explained by intimal hyperplasia in the
normal diet-fed pigs, whereas in atherogenic diet-fed pigs,
intimal hyperplasia resulted in 49 6 23% of the late lumen
loss. Therefore, the major part of late lumen loss is the result
of decrease in the vessel cross-sectional area (44). As in the
rabbit models, intimal hyperplasia may be more marked in
animals fed an atherogenic diet. Andersen et al. (49) reported
similar findings in the LAD of pigs fed a normal diet after
induction of a deep arterial wall injury by inflating and
withdrawing an oversized chain-encircled angioplasty balloon.
Serial coronary angiography revealed that the lumen diameter
changed from 3.4 6 0.4 to 4.2 6 0.6 mm after dilation and to
1.6 6 0.4 mm after 2 to 4 weeks. Postmortem histologic studies
3 weeks after dilation revealed that the injury was deep (had
reached the adventitia) in all arteries and was circumferential
in all but two arteries, with adventitial thickening and neoin-
timal proliferation. There was no correlation between lumen
size and extent of neointimal proliferation. Lumen size corre-
lated with vessel size (r 5 0.74, p 5 0.000005), and the extent
of late loss in lumen diameter observed angiographically
substantially exceeded that caused by neointimal proliferation
seen by histologic analysis. In this model of deep vessel wall
injury, as in many of the other animal models of restenosis,
arterial remodeling was more important than neointimal pro-
liferation in causing late lumen loss (49).
It might be that the mechanism of restenosis is different
after different types of vascular injury (50). Injury that is
associated with intense inflammation (as induced by copper
stent implantation) may lead to more vascular remodeling than
injury that results in less inflammation and more fibrosis, such
as thermal injury. Therefore, injury that causes inflammation
may weaken the arterial wall and thus enable dilation. It is also
possible that the inflammatory process enhances release of
mediators and growth factors that facilitate remodeling. How-
ever, as is discussed later, stent implantation prevents constric-
tion of the arterial wall and promotes intimal proliferation. As
a consequence, it is not clear whether the difference seen is due
to inflammation or to the fact that a stent was implanted,
thereby preventing shrinkage of the vessel total cross-sectional
area.
Human Studies
There are several studies that have found intimal hyperpla-
sia at the site of restenosis and have therefore suggested that
intimal hyperplasia is a major mechanism for restenosis in
humans after PTCA (41,51) (Table 5). However, more recent
data suggest that remodeling may be more important in
determining the final lumen size and, hence, the recurrence of
myocardial ischemia.
Restenosis after PTCA. Mintz et al. (52) investigated the
differences in appearance of primary and restenotic coronary
artery lesions on IVUS. The EEL area at the target lesion and
reference sites and the plaque plus medial area were similar for
vessels with primary and restenotic lesions. However, plaque
burden, defined as (Plaque plus media area) p 100/EEL area,
was smaller in the restenotic lesions (p 5 0.01). Restenotic
lesions also had smaller plaque plus medial area normalized
for the reference segment. The primary and restenotic lesions
had the same distribution of soft, fibrotic and calcific plaque
elements. In contrast, the arc of target lesion calcium and the
Figure 8. Schematic illustration of saphenous vein grafts showing
dilation of the sinuses and therefore an increase in the vessel cross-
sectional area at the valve region. Adapted with permission from Siegel
et al. (28).
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arc of superficial calcium were greater in the restenotic lesions
(52). If restenosis were the result of smooth muscle prolifera-
tion, then plaque mass should be greater in the restenotic
lesions. The composition of restenotic and primary lesions was
similar, except for less plaque burden in the restenotic lesions.
Luo et al. (53) studied patients with clinical and angiographic
evidence of restenosis at an average of 7 6 6 months after
balloon angioplasty and compared them with control patients
after balloon angioplasty without evidence of restenosis. Fig-
ure 9 shows two IVUS studies of a lesion with and one without
restenosis. In the restenotic lesion, lumen area as well as vessel
cross-sectional area are smaller at the lesion site than at the
proximal and distal reference sites. In the lesion without
restenosis, both lumen area and vessel cross-sectional area at
the postangioplasty site are comparable to that of the proximal
and distal reference sites. As shown in Figure 10, the EEL area
at the restenotic lesion sites was smaller than that of both the
proximal and distal reference sites. Vessel wall area was
slightly increased at the angioplasty site. The major lumen loss,
namely 83%, was due to constriction of the vessel, whereas
only 17% of the loss was due to intimal hyperplasia. In 14
patients 7 6 5 months after balloon angioplasty without
evidence of restenosis, the EEL area of the vessel at the
angioplasty site was similar to that of the distal and proximal
reference sites. There was no significant difference in vessel
wall area between the control and restenotic groups (Fig. 8)
(53). Di Mario (54) et al. reported that the plaque increase
accounted for only 32% of late lumen loss after balloon





Studied Diet Duration Findings
Rabbit
Post et al. (44) 33 Iliofemoral Normal 3 and 8 wk after
angioplasty
Average increase in intimal diam was only
14% to 23% of late loss in lumen diam.
Hence, 86% to 77% of late lumen loss
was not explained by intimal hyperplasia
and is probably the result of CSA2
Kakuta et al. (46) 44 Iliac Atherogenic 4 wk IEL was 20% larger in 4-wk group than in
rabbits studied immediately after
procedure. Despite 0.82-mm2 IA1 and
0.15-mm2 MA1, LCSA2 was only
0.34 mm22. The 0.63-mm2 difference was
due to IEL1. Restenotic lesions had
significantly smaller IEL than
nonrestenotic lesions (2.56 6 0.84 vs.
3.22 6 0.83 mm2, p , 0.05)
Lafont et al. (450 33 (36 postangioplasty CAs,
10 control CAs)
Femoral Normal 3–4 wk Neointimal–medial growth was poor
predictor of restenosis. Restenosis could
be explained by EEL2 relative to ref site
Makkar et al. (47) 14 Iliac Normal 8 wk LCSA2 was due to CSA2 rather than
intimal hyperplasia
Gertz et al. (48) Femoral Atherogenic 2 h or 28 days after
angioplasty
EEL area at restenotic sites was comparable
to that of adjacent segments or even
larger. PA1 accounted for LCSA2
Yucatan micropig




Only 11 6 11% and 49 6 23% of % late
lumen diam loss could be explained by
intimal hyperplasia in normal and
atherogenic diet groups, respectively. The
major part of late lumen loss is probably
the result of CSA2.
Pig
Andersen et al. (49) 8 (serial angiography),
9 (histologic analysis)
LAD Normal 3 wk after deep
arterial wall
injury by balloon
No correlation between IA1 and lumen
size. Lumen size correlated with CSA.
Deep arterial wall injury resulted in
shrinkage of arterial wall
Staab et al. (50) 49 CAs Normal High temperature balloon angioplasty (n 5
33); LCSA2 was proportional to
neointimal proliferation. IEL did not
change; EEL tended to 2. Copper
stenting (n 5 16): EEL1, IEL1, massive
neointimal proliferation. LCSA2 was
mild due to remodeling
diam 5 diameter; other abbreviations as in Tables 1 to 3.
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angioplasty. In patients undergoing PTCA, a chronic reduction
in the EEL area was the principal mechanism for restenosis
(67%) and was prevalent in lesions with a mixed or calcific
composition. Restenosis after PTCA could occur despite min-
imal or moderate intimal hyperplasia (54). In a serial IVUS
study, Kimura et al. (55) evaluated coronary artery lesions at












EEL at lesion and ref sites and PA plus MA were similar between
primary and restenotic lesions. Plaque burden [(PA 1 MA) 3
100/EEL] was smaller in restenotic than primary lesions.
Restenotic lesions had smaller PA plus MA normalized for ref
segs. Hence, restenotic lesions are not due to neointimal
proliferation
Luo et al. (53) 17 with, 14 without
restenosis (control)
PTCA 7 6 6 In pts with restenosis, EEL at restenotic lesion sites was smaller
than that of both proximal and distal ref sites (10.1 vs. 14.8 and
13.8 mm2, respectively, p , 0.001), whereas in patients without
restenosis it was similar. Vessel wall area was slightly increased
at angioplasty site (8.0 vs. 7.6 and 6.7 mm2, respectively, p 5
NS). 83% of late LCSA2 could be explained by EEL2. Only
17% of the LCSA2 could be explained by intimal hyperplasia.
There was no difference in vessel wall area between restenotic
and control groups
Di Mario et al. (54) 34 (18 PTCA, 16 DCA) PTCA vs. DCA 6 PA1 accounted for 92% and 32% of restenosis after DCA and
PTCA, respectively. After PTCA, EEL2 accounted for 67% of
restenosis.
Mintz et al. (57,58) 212 primary lesions Transcatheter
interventions
(excluding stent)
73% of LCSA2 (from 6.6 6 2.5 to 4.0 6 3.7 mm2, p , 0.0001)
was due to EEL2, and 27% (from 13.5 6 5.5 to 14.2 6
5.4 mm2, p , 0.0001) was due to increase in PA plus MA.
Change in LCSA correlated more with change in EEL (r 5
0.75, p , 0.0001) than change in MA plus PA (r 5 0.28, p ,
0.0001); 22% of lesions had EEL1. LCSA in these lesions did
not change (decrease of 0.1 6 3.3 mm2), and they had less
restenosis. In lesion with EEL2 at lesion site, LCSA2
significantly (3.6 6 2.3 mm2, p , 0.0001). Despite a greater
MA plus PA1 in lesion with adequate remodeling, these
lesions showed a smaller restenosis rate (26% vs. 62%,
respectively, p , 0.0001) and had a larger incidence of late
LCSA gain (49% vs. 1%, p , 0.0001) than lesions with no
EEL1
de Vrey et al. (60) 18 DCA 6 Plaque volume did not change much at any time point (227 6
93 mm2 before, 198 6 87 mm2 immediately after and 193 6
76 mm2 6 mo after procedure). Progressive lumen loss after the
procedure correlated with gradual 2 in arterial volume (r 5
0.90, p , 0.0001) but not with 1 in plaque volume (r 5 0.25,
p 5 0.07)
Kojima et al. (61) 78 DCA 6 6 6 Good correlation was found between change in PA and change in
CSA (r 5 0.78). Compensatory enlargement of vessel at
restenotic sites was common
Sumitsuji et al. (62) 94 pts DCA Mean 190 d In restenotic lesions (n 5 13), 88% of LCSA2 was due to PA1;
only 12% was due to CSA2. In nonrestenotic lesions (n 5 81),
PA at follow-up was smaller than that in stenotic lesions,
whereas CSA was comparable
Kimura et al. (55) 61 PTCA 6 1 mo after PTCA, there was progressive increase in LCSA and
EEL. During the next 5 mo, EEL2 and LCSA2. Late
LCSA2 (.1 mo) was due to EEL2
Kornowski et al. (56) 60 diabetic pts, 162
nondiabetic pts
PTCA, stent 5.6 Late LCSA2 was more profound in diabetic than nondiabetic pts
(5.2 vs. 2.0 mm2 for stented lesions, 3.2 vs. 2.3 mm2 for
nonstented lesions). Intimal hyperplasia was greater in diabetic
pts (5.0 vs. 1.8 mm2 for restented lesions, 1.3 vs. 0.6 mm2 for
nonstented lesions). CSA1 occurred in 16% of diabetic and
28% of nondiabetic pts
d 5 days; DCA 5 directional coronary atherectomy; PTCA 5 percutaneous transluminal coronary angioplasty; other abbreviations as in Tables 1 to 3.
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baseline, immediately after the procedure and at 24 h and 1
and 6 months after the procedure. Serial changes in lumen
area closely paralleled changes in the EEL area. Early vessel
enlargement (up to 1 month) resulted in a progressive increase
in lumen size, followed by late reduction of the EEL area and
therefore marked reduction in lumen size at 6 months (relative
to 1 month after the procedure). Late constriction of the total
cross-sectional area of the artery was the major mechanism of
restenosis (55).
Patients with diabetes mellitus have an increased rate of
restenosis after transcatheter interventions. In diabetic pa-
tients, intimal hyperplasia may be more profound than in
nondiabetic patients (56). Comparing patients with and with-
out diabetes mellitus, Kornowski et al. (56) found that 5.6
months after procedure, there was greater late lumen loss in
the diabetic patients. The change in cross-sectional area was
comparable between the two groups (1.9 vs. 1.8 mm2). Late
increase in the vessel cross-sectional area occurred in 28% of
the nondiabetic patients but in only 16% of the diabetic
patients (p 5 0.08).
In conclusion, late constriction of the vessel cross-sectional
area and not intimal proliferation appears to be the major
mechanism of restenosis after balloon angioplasty of the
coronary arteries. However, in patients with diabetes mellitus,
intimal proliferation may be more important.
Restenosis after other percutaneous transcatheter-based
interventions. Di Mario et al. (54) compared the mechanisms
of restenosis after PTCA and DCA. Patients treated with
either PTCA or DCA were studied by IVUS before, immedi-
ately after and 6 months after coronary intervention. Plaque
increase was the predominant mechanism of restenosis after
DCA but not after PTCA, accounting for 92% and 32% of the
late lumen loss after DCA and PTCA, respectively. In contrast
to post-PTCA restenosis, DCA caused a more hyperplastic
response due to deeper vessel wall injury (54). Mintz et al.
(57,58) investigated native coronary target lesions in patients
that underwent transluminal catheter interventions. Only pa-
tients that underwent IVUS imaging immediately after the
procedure and at follow-up (due to recurrence of symptoms or
as part of clinical protocols) were analyzed. Patients with stent
implantation at the lesion site, ostial coronary artery lesion and
extensive calcification and those in whom follow-up IVUS
imaging could not be performed were not included in this
study. At follow-up, 73% of the decrease in lumen was due to
a decrease in the EEL area, and only 27% was due to an
increase in plaque plus media area (EEL area minus lumen
area). The change in lumen area correlated more strongly with
the change in the EEL area than with the change in the plaque
plus media area. Forty-seven lesions (22%) had adequate
remodeling (an increase in EEL area). In the lesions with an
increase in EEL area, lumen cross-sectional area was not
changed significantly. In contrast, in the lesion in which the
EEL area at the lesion site decreased, there was a significant
decrease in lumen area. Despite a greater increase in plaque
plus media cross-sectional area in the lesion with adequate
remodeling, these lesions showed a smaller restenosis rate and
had a larger incidence of late lumen area gain than lesions with
no increase in EEL area (57). Mintz et al. (57) found that type
of procedure (balloon angioplasty, DCA, rotational atherec-
tomy or excimer laser angioplasty) did not predict the direction
Figure 9. A, Comparison of lumen area,
vessel wall area and total cross-sectional
area (EEL area, arrows), at the proximal
reference, restenotic and distal reference
sites of coronary arteries with restenosis
after balloon angioplasty. The measure-
ments were made by IVUS. Although there
is no difference in vessel wall area, the vessel
cross-sectional area is smaller at the rest-
enotic sites than at the proximal and distal
reference sites. B, Comparison of lumen
area, vessel wall area and total cross-
sectional area (EEL area, arrows), at the
proximal reference, postangioplasty and dis-
tal reference sites of coronary arteries with-
out restenosis after balloon angioplasty. Lu-
men area and vessel wall area at the
postangioplasty site are similar to the prox-
imal and distal reference sites, and the
vessel cross-sectional area is comparable
among the three groups. Hence, lumen nar-
rowing in restenotic sites is caused by con-
striction of the vessel wall and not by hyper-
plasia of the vessel wall or expansion of the
plaque area. C 5 catheter. Reproduced with
permission from Luo et al. (53).
1160 BIRNBAUM ET AL. JACC Vol. 30, No. 5
VASCULAR REMODELING November 1, 1997:1149–64
or magnitude of the change in EEL area or plaque plus media
area. In contrast to the findings of Di Mario et al. (54), lesion
site remodeling (reduction in lesion EEL area) and not intimal
hyperplasia was the major mechanism of restenosis after DCA
in the Optimal Atherectomy Restenosis Study (OARS) (59)
and Serial Ultrasound Restenosis (SURE) (60) trials. In the
study by Mintz et al. (59) (OARS trial), intimal hyperplasia
accounted for 84% of late lumen loss at follow-up IVUS study.
In the study by de Vrey et al. (60), patients were followed up
for 6 months after DCA (SURE trial). Plaque volume did not
change greatly at 6 months after the procedure relative to that
before and immediately after the procedure. Progressive lu-
men loss after the procedure correlated with a gradual de-
crease in arterial volume but not with the increase in plaque
volume. Kojima et al. (61) also found that 6 6 6 months after
DCA, serial IVUS studies demonstrated good correlation
between the change in plaque area and the change in vessel
size. Compensatory enlargement of the vessel at sites with
plaque expansion was common (61). However, Sumitsuji et al.
(62) found that after aggressive debulking by atherectomy in
the Adjunctive Balloon Angioplasty Following Coronary
Atherectomy Study (ABACAS), 88% of late lumen loss was
due to the increase in plaque area, whereas only 12% was due
to decrease in the cross-sectional area of the vessel. Thus, the
data concerning the mechanism of restenosis after DCA
atherectomy are controversial. Moreover, although some of
the studies reported compensatory enlargement of the vessels
at the lesion site, others found shrinkage. Although it has been
demonstrated (63) that during the first month after balloon
angioplasty or DCA there was an increase in vessel cross-
sectional area, and shrinkage occurred only during the subse-
quent 5 months, the duration of the follow-up period was
comparable among the studies. Thus, differences in duration of
follow-up cannot explain the variance. Perhaps differences in
the depth and extent of tissue removal and, therefore, the
severity and depth of tissue injury and the magnitude of
adjuvant artery balloon dilation are the underlying mecha-
nisms of the differences among the studies.
Restenosis after stent implantation. In stented lesions,
neointimal hyperplasia appears to be the major mechanism for
restenosis (56,58,64). Changes in the cross-sectional area of the
artery within the stent are minimized by the stent (58).
However, restenosis at the proximal or distal margins of the
stent may be due to remodeling (65). In 64 patients studied 6
months after stent implantation, the increase in plaque area
was responsible for 52% of late lumen loss at the proximal
margin of the stent, 96% inside the stent, 12% at the articu-
lation of the stent and 24% at the distal margin of the stent.
Most clinical data indicate that restenosis after transcuta-
neous catheter interventions, except for stent implantation, is
primarily determined by the magnitude of vessel wall remod-
eling. The IVUS studies of Luo et al. (53), Mintz et al. (52) and
Kimura et al. (55) have found that 73% to 83% of lumen loss
is due to remodeling rather than coronary intimal prolifera-
tion. An increase in vessel cross-sectional area (the area
circumscribed by the EEL) is adaptive, whereas a decrease
contributes to lumen narrowing. It may be that after proce-
dures that are associated with more severe and deep vessel wall
injury, such as DCA, and after stent implantation that prevents
remodeling, intimal hyperplasia is more important (54,58).
Mechanism of Vascular Remodeling
Active remodeling of the vessel wall is common both in
native atherosclerotic lesions and after transcatheter interven-
tions. In the early stages of atherosclerotic plaque develop-
ment, compensatory enlargement of the cross-sectional area of
the artery occurs. As the plaque expands and occupies .30%
to 40% of the vessel wall, this adaptive mechanism can no
longer compensate and lumen narrowing occurs. At later
stages, fibrosis and contraction of the plaque may cause
constriction of the arterial wall and augmentation of lumen
narrowing. It is still unclear whether inadequate remodeling is
an early (failure of the adaptive compensatory dilation) or late
event (active arterial shrinkage) (20). However, inadequate
remodeling is more prevalent in lesions with a large arc of
superficial calcium (20). Fibrocalcific elements may limit the
Figure 10. A, IVUS assessment of coronary arteries with restenosis
7 6 6 months after balloon angioplasty. B, IVUS assessment of
coronary arteries without evidence of restenosis on repeated angiog-
raphy 7 6 5 months after balloon angioplasty. The mean lumen area,
vessel wall area and total cross-sectional (CSA) area at the proximal
reference, restenotic and distal reference sites are presented. In the
restenotic lesions, there was a decrease in the total cross-sectional area
of the artery relative to the proximal and distal reference sites.
However, vessel wall area did not change. In the lesions without
restenosis, vessel wall area and total cross-sectional area of the vessel
at the lesion site were comparable to that of the proximal and distal
reference sites. Error bars 5 SD. Reproduced with permission from
Luo et al. (53).
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adaptive remodeling to plaque accumulation (14,20). Alterna-
tively, the maturing atherosclerotic plaque, with its increase in
fibrous and calcific deposits and diminished lipid content as
well as apoptosis, may result in retraction. Consequently, there
may be a decrease in the plaque plus media area and, hence, in
the vessel cross-sectional area as well. Superficial calcium,
which has been associated with inadequate remodeling, may
also be a marker of more advanced atherosclerosis (20).
The arterial wall is composed of intimal, medial and
adventitial layers with endothelial, smooth muscle and fibro-
blast cells (66). These components are coupled to one another
in a complex autocrine–paracrine interaction. The cells in the
vascular wall sense changes within their milieu and integrate
these signals by intercellular communication. Local production
of mediators influences the structure and function of the
arterial wall (66). The intracellular and intercellular mecha-
nisms that lead to compensatory enlargement of the arteries in
early atherosclerosis are not known, but several theories exist:
1. It has been suggested (5,67) that atrophy and thinning of
the media induced by atherosclerosis may lead to weakening of
the arterial wall and, hence, to enlargement. Armstrong et al.
(1) found that the media in atherosclerotic arteries of athero-
genic diet-fed monkeys exhibited focal atrophy and thinning.
Isner et al. (67) demonstrated similar findings of medial
atrophy in the presence of coronary atherosclerosis. Because
the pressure inside the artery is higher than that outside, focal
thinning of the media may lead to progressive passive dilation
of the artery.
2. The vessel wall is affected by changes in shear stress. An
increase in wall shear stress and a decrease in lumen size by the
expanding atheroma may lead to compensatory dilation of the
vessel until normalization of the shear stress (45). However, in
all the studies of early atherosclerosis mentioned before,
lumen area increased during early plaque growth. No study has
documented a bidirectional relation, initial decrease in lumen
and then progression. This suggests that local release of
vasodilator mediators because of a decrease in lumen is
probably not the mechanism. In more advanced lesions, when
vascular narrowing is severe, the reduction in wall tension due
to a Venturi effect could contribute to paradoxic constriction
of the vessel wall.
After arterial wall injury by transcatheter devices (e.g.,
balloon angioplasty, DCA), there might be an initial increase
in vessel cross-sectional area, followed by a further increase or
pathologic shrinkage of the arterial wall, leading to restenosis.
Most likely, the severity and depth of the arterial wall injury;
the extent of the inflammatory reaction; and the pressure, wall
stress and flow through the lesion determine the direction of
vascular remodeling. Adventitial fibrosis may lead to contrac-
tion of the vessel wall in many cases of vascular damage during
percutaneous interventions, especially where there is deep
vessel injury (38,49). During balloon angioplasty in humans,
the rigid atherosclerotic plaque is separated from the more
compliant vessel wall components (plaque-free intima, media
and adventitia). Tears usually extend deeply into the vessel
wall (41,68). The adventitial damage caused by stretch and
tears may trigger inflammation, a proliferative reaction with
subsequent contraction of the adventitial scar that may cause
late lumen narrowing.
IVUS appears currently to be the only reliable technique
for measuring plaque burden and the evolution of atheroscle-
rotic vascular disease. Ideally this method should have been
used in studies investigating the effects of drug interventions,
such as angiotensin-converting enzyme inhibitors, antioxidants
and lipid-lowering agents on the progression and regression of
vascular atherosclerotic lesions (69). However, to date no such
information is available. The invasive aspect of IVUS, the cost
of this procedure, the difficulty in correctly matching sites of
measurement on follow-up studies with the site assessed on the
initial ultrasound study may limit its use in clinical studies using
pharmacotherapy for lesion remodeling (69). However, Lim et
al. (70) recently reported that in transplanted hearts, serial
IVUS studies have shown that early coronary atherosclerosis is
associated with an increase in vessel cross-sectional area that
overcompensates for the increase in intimal area in 49% of
lesions, whereas no compensation or shrinkage was detected in
only 22% of lesions.
Limitations of Studies Reviewed
The studies described in this review used either histomor-
phometric methods or IVUS to measure the various compo-
nents of the artery at the site of interest and to compare them
with either an adjacent reference site with the least atheroma,
a control group without atheroma or the same site at different
time points.
1. Only the minority of the studies used repeated measure-
ments of the same lesions over time. Comparison of the lesion
site with a reference site may be inaccurate because athero-
sclerosis is a diffuse process, and remodeling of the artery may
occur at the early stages of plaque development. Therefore, the
reference site may have already undergone remodeling from
its original size and may not reflect the true reference site.
2. Histomorphometric measurements rely on careful histo-
logic techniques that aim to minimize the contraction of the
artery during processing. Hence, in some of the studies, lumen
diameter was measured by in vivo angiography, and changes in
lumen area, measured by histologic analysis, were verified by
angiographic measurements.
Conclusions
The human arterial system is not composed of rigid pipes.
Rather, the arterial wall is a biologically active integrated
organ, composed of endothelial cells, smooth muscle cells,
fibroblasts, collagen, elastin and other extracellular proteins
and a vascularized adventitial outer layer. Arterial wall remod-
eling is common both in primary atherosclerotic lesions and
after transcatheter interventions and is a major determinant of
lumen size. Early in the course of atherosclerosis, compensa-
tory enlargement predominates and delays the development of
lumen narrowing. However, in more advanced stages of ath-
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erosclerosis when the plaque occupies .30% to 40% of the
vessel area, and especially after deep vascular wall injury (as
seen after percutaneous interventions), this protective mecha-
nism fails, and inflammatory changes and fibrosis may lead to
constriction of the arterial wall. This pathologic remodeling
seems to be the principal mechanism of restenosis after
percutaneous intracoronary interventions.
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